-
1
-
-
0036881507
-
Antithrombin deficiency: Issues in laboratory diagnosis
-
Kottke-Marchant K, Duncan A. Antithrombin deficiency: issues in laboratory diagnosis. Arch Pathol Lab Med 2002;126:1326-36.
-
(2002)
Arch Pathol Lab Med
, vol.126
, pp. 1326-1336
-
-
Kottke-Marchant, K.1
Duncan, A.2
-
2
-
-
0029593690
-
Clinical relevance of antithrombin deficiencies
-
Mammen EF. Clinical relevance of antithrombin deficiencies. Sem Hematol 1995;32(suppl):2-6.
-
(1995)
Sem Hematol
, vol.32
, Issue.SUPPL.
, pp. 2-6
-
-
Mammen, E.F.1
-
3
-
-
0031801933
-
Syndromes of thrombosis and hypercoagulability: Congenital and acquired causes of thrombosis
-
Bick RL, Kaplan H. Syndromes of thrombosis and hypercoagulability: congenital and acquired causes of thrombosis. Med Clin North Am 1998;82:409-58.
-
(1998)
Med Clin North Am
, vol.82
, pp. 409-458
-
-
Bick, R.L.1
Kaplan, H.2
-
4
-
-
0017618237
-
Crossed immunoelectrophoresis as applied to studies on complex formation: The binding of heparin to antithrombin III and the antithrombin-thrombin complex
-
Andersson LO, Engman L, Henningson E. Crossed immunoelectrophoresis as applied to studies on complex formation: the binding of heparin to antithrombin III and the antithrombin-thrombin complex. J Immunol Methods 1977;14:271-81.
-
(1977)
J Immunol Methods
, vol.14
, pp. 271-281
-
-
Andersson, L.O.1
Engman, L.2
Henningson, E.3
-
6
-
-
0025769392
-
Anticoagulant therapy in a congenital antithrombin III (ATIII)-deficient patient with chronic renal failure undergoing regular hemodialysis
-
Matsuo T, Yamada T, Matsue M, Sakai R. Anticoagulant therapy in a congenital antithrombin III (ATIII)-deficient patient with chronic renal failure undergoing regular hemodialysis. Biomater Artif Cells Immobilization Biotechnol 1991;19:185-91.
-
(1991)
Biomater Artif Cells Immobilization Biotechnol
, vol.19
, pp. 185-191
-
-
Matsuo, T.1
Yamada, T.2
Matsue, M.3
Sakai, R.4
-
7
-
-
0030820375
-
Application of argatroban, direct thrombin inhibitor, in heparin-intolerant patients requiring extracorporeal circulation
-
Matsuo T, Koide M, Kario K. Application of argatroban, direct thrombin inhibitor, in heparin-intolerant patients requiring extracorporeal circulation. Artif Organs 1997;21:1035-48.
-
(1997)
Artif Organs
, vol.21
, pp. 1035-1048
-
-
Matsuo, T.1
Koide, M.2
Kario, K.3
-
8
-
-
0035652424
-
Successful use of argatroban as an anticoagulant in burn-related severe acquired antithrombin III deficiency after heparin failure
-
Gorman R, Gordon L, Zumberg M, Kitchens C. Successful use of argatroban as an anticoagulant in burn-related severe acquired antithrombin III deficiency after heparin failure. Thromb Haemost 2001;86:1596-7.
-
(2001)
Thromb Haemost
, vol.86
, pp. 1596-1597
-
-
Gorman, R.1
Gordon, L.2
Zumberg, M.3
Kitchens, C.4
-
9
-
-
26144449953
-
Long-term treatment with subcutaneous lepirudin in a patient with antithrombin deficiency and factor v leiden
-
Ravoet C, Petit B, Thomas T, et al. Long-term treatment with subcutaneous lepirudin in a patient with antithrombin deficiency and factor v leiden [abstr]. Blood 2002;100:122b.
-
(2002)
Blood
, vol.100
-
-
Ravoet, C.1
Petit, B.2
Thomas, T.3
-
10
-
-
0033769598
-
Successful anticoagulation with hirudin in a patient with mesenteric venous thrombosis and multiple coagulation abnormalities
-
Gordon MB, Beckman JA. Successful anticoagulation with hirudin in a patient with mesenteric venous thrombosis and multiple coagulation abnormalities. Vasc Med 2000;5:159-62.
-
(2000)
Vasc Med
, vol.5
, pp. 159-162
-
-
Gordon, M.B.1
Beckman, J.A.2
-
11
-
-
0019579602
-
Antithrombin III deficiency
-
Thaler E, Lechner K. Antithrombin III deficiency. Clin Haematol 1981;10:369-78.
-
(1981)
Clin Haematol
, vol.10
, pp. 369-378
-
-
Thaler, E.1
Lechner, K.2
-
12
-
-
0026749276
-
Deep vein thrombosis: Prevalence of etiologic factors and results of management in 100 consecutive patients
-
Bick RL, Jakway J, Baker WF. Deep vein thrombosis: prevalence of etiologic factors and results of management in 100 consecutive patients. Semin Thromb Hemost 1992;18:267-74.
-
(1992)
Semin Thromb Hemost
, vol.18
, pp. 267-274
-
-
Bick, R.L.1
Jakway, J.2
Baker, W.F.3
-
13
-
-
4944236861
-
Effect of direct-thrombin-inhibitor (DTI) anticoagulants on INR measurements and other coagulation studies
-
Gosselin RC, Dager WE, King JH, et al. Effect of direct-thrombin-inhibitor (DTI) anticoagulants on INR measurements and other coagulation studies [abstr]. Blood 2003;102:810a-11.
-
(2003)
Blood
, vol.102
-
-
Gosselin, R.C.1
Dager, W.E.2
King, J.H.3
-
14
-
-
2342525603
-
-
Research Triangle Park, NC
-
GlaxoSmithKline. Argatroban product information. Research Triangle Park, NC; 2002.
-
(2002)
Argatroban Product Information
-
-
-
15
-
-
0037863848
-
Argatroban anticoagulation during renal replacement therapy in patients with heparin-induced thrombocytopenia
-
Reddy BV, Grossman EJ, Nahlik L, Trevino S, Murray PT. Argatroban anticoagulation during renal replacement therapy in patients with heparin-induced thrombocytopenia [abstr]. J Am Soc Nephrol 2002;13:604a.
-
(2002)
J Am Soc Nephrol
, vol.13
-
-
Reddy, B.V.1
Grossman, E.J.2
Nahlik, L.3
Trevino, S.4
Murray, P.T.5
|